FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the 11th Annual BIO CEO and Investor Conference on Tuesday, February 10 at 9:30 a.m. Eastern Time. The presentation is being held in the West Foyer at the Waldorf Astoria in New York City.
